Differences in epileptic symptoms depending on the type of autoimmune-mediated limbic encephalitis

References

• Brierley JB, Corsellis JAN, Hierons R, et al. Subacute encephalitis of later adult life. Mainly affecting the limbic areas. Brain 1960;83:357-68
   Web of Science ®Google Scholar
• Corsellis JA, Goldberg GJ, Norton AR. “Limbic encephalitis” and its association with carcinoma. Brain 1968;91:481-96
   PubMed Web of Science ®Google Scholar
• Rosenfeld MR, Titulaer MJ, Dalmau J. Paraneoplastic syndromes and autoimmune encephalitis: Five new things. Neurol Clin Pract 2012;2(3):215-23
   Google Scholar
• Rudzinski LA, Pittock SJ, McKeon A, et al. Extra-temporal EEG and MRI findings in ANNA-1 (anti-Hu) encephalitis. Epilepsy Res 2011;95:255-62
   Google Scholar
• Irani SR, Michell AW, Lang B, et al. Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 2011;l69:892-900
   Google Scholar
• Pandit AK, Ihtisham K, Garg A, et al. Autoimmune encephalitis: a potentially reversible cause of status epilepticus, epilepsy, and cognitive decline. Ann Indian Acad Neurol 2013;16:577-84
   Google Scholar
• Labate A, Irani SR, Vincent A, et al. Anti-NMDA receptor encephalitis: a video case report. Epileptic Disord 2009;11(3):267-9
   Google Scholar
• Muehlebner A, Groeppel G, Pahs G, et al. Beneficial effect of epilepsy surgery in a case of childhood non-paraneoplastic limbic encephalitis. Epilepsy Res 2010;90:295-9
   Google Scholar
• Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-8
   PubMed Web of Science ®Google Scholar
• Kotsenas AL, Watson RE, Pittock SJ, et al. MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. Am J Neuroradiol 2013;35:84-9
   Google Scholar
• Bonello M, Larner AJ, Marson AG. Profound amnesia after temporal lobectomy: an autoimmune process resembling patient h.m.? Case Rep Neurol 2014;6(3):251-5
   Google Scholar
• Toyota T, Akamatsu N, Tsuji S, et al. Limbic Encephalitis Associated with Anti-Voltage-Gated Potassium Channel Complex Antibodies as a Cause of Adult-Onset Mesial Temporal Lobe Epilepsy. J UOEH 2014;36(2):129-33
   Google Scholar
• Sarria-Estrada S, Toledo M, Lorenzo-Bosquet C, et al. Neuroimaging in status epilepticus secondary to paraneoplastic autoimmune encephalitis. Clin Radiol 2014;69:795-803
   Google Scholar
• Sarkis RA, Nehme R, Chemali ZN. Neuropsychiatric and seizure outcomes in nonparaneoplastic autoimmune limbic encephalitis. Epilepsy Behav 2014;39:21-5
   PubMed Web of Science ®Google Scholar
• Quek AM, Britton JW, McKeon A, et al. Autoimmune epilepsy: Clinical characteristics and response to immunotherapy. Arch Neurol 2012;69(5):582-93
   PubMedGoogle Scholar
• Wagner J, Schoene-Bake JC, Malter MP, et al. Quantitative FLAIR analysis indicates predominant affection of the amygdalal in antibody-associated limbic encephalitis. Epilepsia 2013;54(9):1679-87
   Google Scholar
• Soeder BM, Gleissner U, Urbach H, et al. Causes, presentation and outcome of lesional adult onset mediotemporal lobe epilepsy. J Neurol Neurosurg Psychiat 2009;80:894-9
   Google Scholar
• Alamowitch S, Graus F, Uchuya M, et al. Limbic encephalitis and small cell lung cancer. Clinical and immunological features. Brain 1997;120(6):923-8
   Google Scholar
• Granata T, Cross H, Theodore W, et al. Immune-mediated epilepsies. Epilepsia 2011;52:5
   PubMedGoogle Scholar
• Nabbout R. Autoimmune and inflammatory epilepsies. Epilepsia 2012;53:58-62
   PubMedGoogle Scholar
• Lancaster E, Martinez-Hernandez E, Dalmau J. Encephalitis and antibodies to synaptic and neuronal cell surface proteins. Neurology 2011;77:179-89
   PubMed Web of Science ®Google Scholar
• Gultekin SH, Rosenfeld MR, Voltz R, et al. Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain 2000;123(7):1481-94
   PubMed Web of Science ®Google Scholar
• Shavit YB, Graus F, Probst A, et al. Epilepsia partialis continua: a new manifestation of anti-Hu-associated paraneoplastic encephalomyelitis. Ann Neurol 1999;45:255-8
   PubMedGoogle Scholar
• Drislane FW. Non-convulsive status epilepticus in patients with cancer. Clin Neurol Neurosurg 1994;96:314-18
   PubMed Web of Science ®Google Scholar
• Demaerel P, Van Dessel W, Van Paesschen W, et al. Autoimmune-mediated encephalitis. Neuroradiology 2011;53:837-51
   Google Scholar
• Jacobs DA, Fung KM, Cook NM, et al. Complex partial status epilepticus associated with anti-Hu paraneoplastic syndrome. J Neurol Sci 2003;213:77-82
   Google Scholar
• Rocamora R, Becerra JL, Fossas P, et al. Pilomotor seizures: An autonomic semiology of limbic encephalitis? Seizure 2014;23:670-3
   Google Scholar
• Fadul CE, Stommel EW, Dragnev KH, et al. Focal paraneoplastic limbic encephalitis presenting as orgasmic epilepsy. J Neuro-Oncol 2005;72:195-8
   PubMed Web of Science ®Google Scholar
• Pitkanen A, Sutula T. Is epilepsy a progressive disorder? Prospects for new therapeutic approaches in temporal-lobe epilepsy. Lancet Neurol 2002;1:173-81
   PubMed Web of Science ®Google Scholar
• Vezzani A, French J, Bartfai T, et al. The role of inflammation in epilepsy. Nat Rev Neurol 2011;7:31-40
   PubMed Web of Science ®Google Scholar
• Librizzi L, Noe F, Vezzani A, et al. Seizure-induced brain-borne inflammation sustains seizure recurrence and blood–brain barrier damage. Ann Neurol 2012;72:82-90
   PubMed Web of Science ®Google Scholar
• Vezzani A, Balosso S, Ravizza T. The role of cytokinesin the pathophysiology of epilepsy. Brain Behav Immun 2008;22:797-803
   PubMed Web of Science ®Google Scholar
• Vincent A, Bien CG, Irani SR, et al. Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 2011;10:759-72
   PubMed Web of Science ®Google Scholar
• Buckley C, Oger J, Clover L, et al. Potassium channel antibodies in two patients with reversible limbic encephalitis. Ann Neurol 2001;50:73-8
   PubMed Web of Science ®Google Scholar
• Irani SR, Alexander S, Waters P, et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, gliomain activated 1 protein and contactin-associated protein-2 in limbic encephalitis. Morvan’s syndrome and acquired neuromyotonia. Brain 2010;133:2734-48
   PubMed Web of Science ®Google Scholar
• Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 2004;127:701-12
   PubMed Web of Science ®Google Scholar
• Boyd M, Attarian H, Raizer J, et al. Auditory hallucinations asictal phenomena in a patient with voltage-gated potassium channel antibody-associated limbic encephalitis. Epileptic Disord 2013;15(4):433-6
   Google Scholar
• Toyota T, Akamatsu N, Tsuji S, et al. Limbic Encephalitis Associated with Anti-Voltage-Gated Potassium Channel Complex Antibodies as a Cause of Adult-Onset Mesial Temporal Lobe Epilepsy. J UOEH 2014;36(2):129-33
   Google Scholar
• Pozo-Rosich P, Clover L, Saiz A, et al. Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol 2003;54:530-3
   PubMed Web of Science ®Google Scholar
• Tan KM, Lennon VA, Klein CJ, et al. Clinical spectrum of voltage-gated potassium channel autoimmunity. Neurology 2008;70:1883-90
   PubMed Web of Science ®Google Scholar
• Jacob S, Irani SR, Rajabally YA, et al. Hypothermia in VGKC antibody-associated limbic encephalitis. J Neurol Neurosurg Psychiatr 2008;79:202-4
   Google Scholar
• Thieben MJ, Lennon VA, Boeve BF, et al. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology 2004;62:1177-82
   PubMed Web of Science ®Google Scholar
• Lai M, Huijbers MG, Lancaster E, et al. Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: A case series. Lancet Neurol 2010;9:776-85
   PubMed Web of Science ®Google Scholar
• Ohkawa T, Fukata Y, Yamasaki M, et al. Autoantibodies to Epilepsy-Related LGI1 in Limbic Encephalitis Neutralize LGI1-ADAM22 Interaction and Reduce Synaptic AMPA Receptors. J Neurosci 2013;33(46):18161-74
   PubMed Web of Science ®Google Scholar
• Lalic T, Pettingill P, Vincent A, et al. Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3pyramidal cell synaptic transmission. Epilepsia 2011;52:121-31
   Google Scholar
• Lee JJ, Lee ST, Jung KH, et al. Anti-LGI1 Limbic Encephalitis Presented with Atypical Manifestations. Exp Neurobiol 2013;22(4):337-40
   Google Scholar
• Irani SR, Stagg CJ, Schott JM, et al. Faciobrachial dystonic seizures: the influence of immunotherapy on seizure control and prevention of cognitive impairment in a broadening phenotype. Brain 2013;136:3151-62
   PubMed Web of Science ®Google Scholar
• Irani SR, Bien CG, Lang B. Autoimmune epilepsies. Curr Opin Neurol 2011;24:146-53
   PubMed Web of Science ®Google Scholar
• Yoo JY, Hirsch LJ. Limbic encephalitis associated with anti–voltage-gated potassium channel complex antibodies mimicking Creutzfeldt-Jakob disease. JAMA Neurol 2014;71(1):79-82
   Google Scholar
• Lilleker JB, Jones MS, Mohanraj R. VGKC complex antibodies in epilepsy: Diagnostic yield and therapeutic implications. Seizure 2013;22:776-9
   Google Scholar
• Vitaliani R, Mason W, Ances B, et al. Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma. Ann Neurol 2005;58(4):594-604
   PubMed Web of Science ®Google Scholar
• Rosenfeld MR, Dalmau JO. Paraneoplastic disorders of the CNS and autoimmune synaptic encephalitis. Continuum (Minneap Minn) 2012;18:366-83
   Google Scholar
• Zandi MS, Irani SR, Follows G, et al. Limbic encephalitis associated with antibodies to the NMDA receptor in Hodgkin lymphoma. Neurology 2009;73:2039-40
   Google Scholar
• Graus F, Saiz A, Lai M, et al. Neuronal surface antigen antibodies in limbic encephalitis: Clinical-immunologic associations. Neurology 2008;71:930-6
   PubMed Web of Science ®Google Scholar
• Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009;66:11-18
   PubMed Web of Science ®Google Scholar
• Dalmau J, Lancaster E, Martinez-Hernandez E, et al. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011;10:63-74
   PubMed Web of Science ®Google Scholar
• Schmitt SE, Pargeon K, Frechette ES, et al. Extreme delta brush unique EEG pattern in adults with anti-NMDA receptor encephalitis. Neurology 2012;79:1094-100
   PubMed Web of Science ®Google Scholar
• Titulaer MJ, McCracken L, Gabionade I, et al. Late-onset anti–NMDA receptor encephalitis. Neurology 2013;81:1058-63
   PubMed Web of Science ®Google Scholar
• Hughes EG, Peng X, Gleichman AJ, et al. Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 2010;30(17):5866-75
   PubMed Web of Science ®Google Scholar
• Marsden KC, Beattie JB, Friedenthal J, et al. NMDA receptor activation potentiates inhibitory transmission through GABA receptor-associated protein-dependent exocytosis of GABA(A) receptors. J Neurosci 2007;27(52):14326-37
   Google Scholar
• Iizuka T, Sakai F, Ide T, et al. Anti-NMDA receptor encephalitis in Japan: Long-term outcome without tumor removal. Neurology 2008;70(7):504-11
   PubMed Web of Science ®Google Scholar
• Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-8
   PubMed Web of Science ®Google Scholar
• Irani SR, Vincent A. NMDA receptor antibody encephalitis. Curr Neurol Neurosci Rep 2011;11:298-304
   PubMed Web of Science ®Google Scholar
• Viaccoz A, Desestret V, Ducray F, et al. Clinical specificities of adult male patients with NMDA receptor antibodies encephalitis. Neurology 2014;82(7):556-63
   PubMed Web of Science ®Google Scholar
• Niehusmann P, Dalmau J, Rudlowski C, et al. Diagnostic value of N-methyl-d-aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 2009;66:458-64
   Google Scholar
• Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013;12:157-65
   PubMed Web of Science ®Google Scholar
• Gabilondo I, Saiz A, Galan L, et al. Analysis of relapses in anti-NMDAR encephalitis. Neurology 2011;77:996-9
   PubMed Web of Science ®Google Scholar
• Frisch C, Malter MP, Elger CE, et al. Neuropsychological course of voltage-gated potassium channel and glutamic acid decarboxylase antibody related limbic encephalitis. Eur J Neurol 2013;20(9):1297-304
   PubMed Web of Science ®Google Scholar
• Malter MP, Helmstaedter C, Urbach H, et al. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol 2010;67:470-8
   PubMed Web of Science ®Google Scholar
• Vianello M, Tavolato B, Giometto B. Glutamic acid decarboxylase autoantibodies and neurological disorders. Neurol Sci 2002;23:145-51
   PubMed Web of Science ®Google Scholar
• Bonello M, Larner AJ, Marson AG. Profound Amnesia after Temporal Lobectomy: An Autoimmune Process Resembling Patient H.M.? Case Rep Neurol 2014;6:251-5
   Google Scholar
• Farooqi MS, Lai Y, Lancaster E, et al. Therapeutic plasma exchange and immunosuppressive therapy in a patient with anti-GAD antibody-related epilepsy: quantification of the antibody response. J Clin Apher 2014;00:1-7
   Google Scholar
• Kumar G, Mittalb S, Moudgil SS, et al. Histopathological evidence that hippocampal atrophy following status epilepticus is a result of neuronal necrosis. J Neurolog Sci 2013;334:186-91
   Google Scholar
• Errichiello L, Perruolo G, Pascarella A, et al. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: A study on 233 patients. J Neuroimmunol 2009;211:120-3
   PubMed Web of Science ®Google Scholar
• Wong SH, Saunders M, Larner AJ, et al. An effective immunotherapy regimen for VGKC antibody-positive limbic encephalitis. J Neurol Neurosurg Psychiatr 2010;81:1167-9
   PubMed Web of Science ®Google Scholar
• Finelli PF. Autoimmune limbic encephalitis with GAD antibodies. Neurohospitalist 2011;1(4):178-81
   Google Scholar
• Kanter IC, Huttner HB, Staykov D, et al. Cyclophosphamide for anti-GAD antibody-positive refractory status epilepticus. Epilepsia 2008;49(5):914-20
   PubMed Web of Science ®Google Scholar
• Mazzi G, Roia DD, Cruciatti B, et al. Plasma exchange for anti-GAD associated non paraneoplastic limbic encephalitis. Transfus Apher Sci 2008;39:229-33
   Google Scholar
• Kobayakawa Y, Tateishi T, Kawamura N, et al. A case of immune-mediated encephalopathy showing refractory epilepsy and extensive brain MRI lesions associated with anti-glutamic acid decarboxylase antibody. Rinsho Shinkei-gaku 2010;50:92-7
   Google Scholar
• Korff CM, Parvex P, Cimasoni L, et al. Encephalitis associated with glutamic acid decarboxylase auto-antibodies in a child: a treatable condition? Arch Neurol 2011;68:1065-8
   Google Scholar
• Boronat A, Sabater L, Saiz A, et al. GABAB receptor antibodies in limbic encephalitis and anti-GAD–associated neurologic disorders. Neurology 2011;76:795-800
   PubMed Web of Science ®Google Scholar
• Höftberger R, Titulaer MJ, Sabater L, et al. Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients. Neurology 2013;81(17):1500-6
   PubMed Web of Science ®Google Scholar
• Graus F, Boronat A, Xifro′ X, et al. The expanding clinical profile of anti-AMPA receptor encephalitis. Neurology 2010;74:857-9
   PubMed Web of Science ®Google Scholar
• Lancaster E, Lai MZ, Hughes E, et al. Autoantibodies to the GABA(B) receptor associate with limbic encephalitis and seizures, and alter GABA(B) receptor function. Neurology 2010;74(suppl 2):A402
   Google Scholar
• Lancaster E, Lai MZ, Peng XY, et al. Antibodies to the GABAB receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 2010;9:67-76
   PubMed Web of Science ®Google Scholar
• Dogan Onugoren M, Deuretzbacher D, Haensch CA, et al. Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. J Neurol Neurosurg Psychiatry 2014;0:1-8
   Google Scholar
• Petit-Pedrol M, Armangue T, Peng X, et al. Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies. Lancet Neurol 2014;13:276-86
   PubMed Web of Science ®Google Scholar
• Hainsworth JB, Shishido A, Theeler BJ, et al. Treatment responsive GABA(B)-receptor limbic encephalitis presenting as new-onset super-refractory status epilepticus (NORSE) in a deployed U.S. soldier. Epileptic Disord 2014;16(4):486-93
   Google Scholar
• Peng X, Hughes EG, Moscato EH, et al. Cellular plasticity induced by anti-AMPA receptor encephalitis antibodies. Ann Neurol 2015;7(3):381-98
   Google Scholar
• Bataller L, Galiano R, Garcia-Escrig M, et al. Reversible paraneoplastic limbic encephalitis associated with antibodies to the AMPA receptor. Neurology 2010;74:265-7
   PubMed Web of Science ®Google Scholar
• Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 2009;65:424-34
   PubMed Web of Science ®Google Scholar
• Urbach H, Soeder BM, Jeub M, et al. Serial MRI of limbic encephalitis. Neuroradiology 2006;8:380-6
   Google Scholar
• Suleiman J, Brenner T, Gill D, et al. VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 2011;76:1252-5
   Google Scholar
• Kruer MC, Hoeftberger R, Lim KY, et al. Aggressive course in encephalitis with opsoclonus, ataxia, chorea, and seizures. JAMA Neurol 2014;71:620-3
   Google Scholar
• Dhamija R, Renaud DL, Pittock SJ, et al. Neuronal voltage-gated potassium channel complex autoimmunity in children. Pediatr Neurol 2011;44:275-81
   Google Scholar
• Dirr LY, Elster AD, Donofrio PD, et al. Evolution of brain MRI abnormalities in limbicencephalitis. Neurology 1990;40:1304-6
   Google Scholar
• Baumgartner A, Rauer S, Mader I, et al. Cerebral FDG-PET and MRI findings in autoimmune limbic encephalitis: correlation with autoantibody types. J Neurol 2013;260:2744-53
   Google Scholar
• Fauser S, Talazko J, Wagner K, et al. FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology. Acta Neurol Scand 2005;111:338-4
   PubMed Web of Science ®Google Scholar
• Spatola M, Stojanova V, Prior JO, et al. Serial brain 18FDG-PET in anti-AMPA receptor limbic encephalitis. J Neuroimmunol 2014;271(1-2):53-5
   Google Scholar
• Park S, Choi H, Cheon GJ, et al. 18F-FDG PET/CT in anti-LGI1 encephalitis: initial and follow-up findings. Clin Nucl Med 2015;40(2):156-8
   Google Scholar
• Kimura N, Kumamoto T, Takahashi Y. Brain perfusion SPECT in limbic encephalitis associated with autoantibody against the glutamate receptor epsilon 2. Clin Neurol Neurosurg 2014;118:44-8
   Google Scholar
• Vincent A. Stiff, twitchy or wobbly-are GAD antibodies pathogenic? Brain 2008;131:2536-7
   PubMed Web of Science ®Google Scholar
• Kirkpatrick MP, Clarke CD, Sonmezturk HH, et al. Rhythmic delta activity represents a form of non convulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 2011;20:392-4
   PubMed Web of Science ®Google Scholar
• Pessa ME, Janes F, Gigli GL. Electroencephalographic Evaluation for Early Diagnosis of Limbic Encephalitis. Clin EEG Neurosci 2014. [ Epub ahead of print
   Google Scholar
• Gu Y, Yang Q, Wang XF. Epilepsy in women with gynecgynaecologic malignancies. Expert Rev Neurother 2014;14(5):503-17
   PubMed Web of Science ®Google Scholar
• Sabin TD, Jednacz JA, Staats PN. Case records of the Massachusetts General hospital. Case 26-2008: A 26 –year old woman with headache and behavioural changes. N Engl J Med 2008;359(8):842-53
   Google Scholar
• Ramanathan S, Mohammad SS, Brilot F, et al. Autoimmune encephalitis: Recent updates and emerging challenges. J Clin Neurosci 2014;21(5):722-30
   PubMed Web of Science ®Google Scholar
• Wang W, Zheng HB, Xiao J, et al. Levetiracetam effect on adult-onset temporal lobe epilepsy with positive voltage-gated potassium channel antibody. J Neuropsychiatry Clin Neurosci 2015;27(2):e100-6
   Google Scholar
• Batty N, Malouf GG, Issa JP. Histone deacetylase inhibitors as anti-neoplasticagents. Cancer Lett 2009;280:192-200
   PubMed Web of Science ®Google Scholar
• Singh G, Driever PH, Sander JW. Cancer risk in people with epilepsy: the role of antiepileptic drugs. Brain 2005;128:7-17
   PubMed Web of Science ®Google Scholar
• Honnorat J, Cartalat-Carel S, Ricard D, et al. Onconeural anti-bodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 anti-bodies. J Neurol Neurosurg Psychiatry 2009;80:412-16
   PubMed Web of Science ®Google Scholar
• Knight AK, Cunningham-Rundles C. Oxcarbazepine-induced immunoglobulin deficiency. Clin Diagn Lab Immunol 2005;12:560-1
   Google Scholar
• Blanc F, Rupert E, Kleitz C, et al. Acute limbic encephalitis and glutamic acid decarboxylase antibodies: A reality? J Neurol Sci 2009;287:69-71
   Google Scholar
• Kröll-Seger J, Bien CG, Huppertz HJ. Non-paraneoplastic limbic encephalitis associated with antibodies to potassium channels leading to bilateral hippocampal sclerosis in a pre-pubertal girl. Epileptic Disord 2009;11(1):54-9
   Google Scholar
• Shorvon S. Guidelines for Status Epilepticus: Are We There Yet? Neurocrit Care 2012;17:1-2
   Google Scholar
• Shorvon S, Baulac M, Cross H, et al. The drug treatment of status epilepticus in Europe: consensus document from a workshop at the first London Colloquium on Status Epilepticus. Epilepsia 2008;49:1277-85
   PubMed Web of Science ®Google Scholar
• Zhao X, Wang X. Anesthesia-induced epilepsy: causes and treatment. Expert Rev Neurother 2014;14(9):1099-113
   PubMed Web of Science ®Google Scholar
• Shorvon S, Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012;135(Pt 8):2314-28
   PubMedGoogle Scholar
• Chang HR, Kuo CC. Molecular determinants of the anticonvulsant felbamate binding site in the N-methyl-D-aspartate receptor. J Med Chem 2008;51:1534-45
   Google Scholar
• Harty TP, Rogawski MA. Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit. Epilepsy Res 2000;39:47-55
   PubMed Web of Science ®Google Scholar
• Almeida V, Pimentel J, Alexandre Campos A, et al. Surgical control of limbic encephalitis associated with LGI1 antibodies. Epileptic Disord 2012;14:3-345-8
   Google Scholar
• Weimer T, Boling W, Pryputniewicz D, et al. Temporal lobectomy for refractory status epilepticus in a case of limbic encephalitis. J Neurosurg 2008;109(4):742-5
   Google Scholar
• Haberlandt E, Bast T, Ebner A, et al. Limbic encephalitis in children and adolescents. Arch Dis Child 2011;96:186-91
   Google Scholar
• Barber PA, Anderson NE, Vincent A. Morvan’s syndrome associated with voltage-gated K+channel anti-bodies. Neurology 2000;54:771-2
   PubMed Web of Science ®Google Scholar
• Dale RC, Irani SR, Brilot F, et al. N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 2009;66:704-9
   Web of Science ®Google Scholar
• Dalmau J, Tuzun E, Wu HY, et al. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36
   PubMed Web of Science ®Google Scholar
• Saiz A, Blanco Y, Sabater L, et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 2008;131:2553-63
   PubMed Web of Science ®Google Scholar
• Akman CI, Patterson MC, Rubinstein A, et al. Limbic encephalitis associated with anti-GAD antibody and common variable immune deficiency. Dev Med Child Neurol 2009;51:563-7
   Google Scholar
• Pittock SJ, Lucchinetti CF, Parisi JE, et al. Amphiphysin autoimmunity: Paraneoplastic accompaniments. Ann Neurol 2005;58:96-107
   PubMed Web of Science ®Google Scholar
• Hoffmann LA, Jarius S, Pellkofer HL, et al. Anti-Ma and anti-Ta associated paraneoplastic neurological syndromes: 22 newly diagnosed patients and review of previous cases. J Neurol Neurosurg Psychiatry 2008;79:767-73
   PubMedGoogle Scholar
• Honnorat J, Cartalat-Carel S, Ricard D, et al. Onconeural anti-bodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2/CRMP5 anti-bodies. J Neurol Neurosurg Psychiatry 2009;80:412-16
   PubMed Web of Science ®Google Scholar
• Abraham S, Shaju M. Innovations in Epilepsy Management – An Overview. J Pharm Pharm Sci 2013;16(4):564-76
   PubMedGoogle Scholar